Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial
By 2024, Ozempic had surpassed Trulicity, also approved for type 2 diabetes (not obesity) to make up the largest share of GLP-1 prescriptions and spending (39% in 2024)
overnight emergency rescue 2
During the evaluation, a licensed provider reviews relevant information and determines whether compounded medication may be incorporated as part of a broader program that also considers nutrition habits, consistency, and long-term support
The IRS treats prescribed drugs for a diagnosed disease as qualified medical expenses under Section 213(d), so GLP-1s can be eligible on paper but employer-funded HRAs, and to a lesser extent FSAs and HSAs, are governed by plan documents that can be narrower than IRS rules
There was a clear difference between groups in the Mattis cognitive assessment tests as well
